IQVIA Holdings Inc. (LON:0JDM)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 24.40B |
| Revenue (ttm) | 12.31B |
| Net Income (ttm) | 1.10B |
| Shares Out | n/a |
| EPS (ttm) | 5.98 |
| PE Ratio | 22.25 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 166 |
| Average Volume | 7,835 |
| Open | 177.42 |
| Previous Close | 179.26 |
| Day's Range | 176.27 - 177.99 |
| 52-Week Range | 166.94 - 261.42 |
| Beta | n/a |
| RSI | 35.34 |
| Earnings Date | Apr 25, 2025 |
About IQVIA Holdings
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ... [Read more]
Financial Performance
In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.
Financial numbers in USD Financial StatementsNews
IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life scien...
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an adva...
Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation
UPPER NYACK, N.Y.--(BUSINESS WIRE)--When pharmacists can't give adult vaccinations, millions of people go without them.
IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences and healthcar...
IQVIA Holdings Inc (IQV) Announces CFO's Participation in TD Cowen Annual Health Care Conference
IQVIA Holdings Inc (IQV) Announces CFO's Participation in TD Cowen Annual Health Care Conference
IQVIA Holdings Inc (IQV) Releases 2024 Sustainability Report Highlighting Key Achievements
IQVIA Holdings Inc (IQV) Releases 2024 Sustainability Report Highlighting Key Achievements
IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the TD C...
IQVIA Releases 2024 Sustainability Report
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way
IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and 2033, w...
IQVIA Holdings Inc. 2024 Q4 - Results - Earnings Call Presentation
The following slide deck was published by IQVIA Holdings Inc.
IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
On Thursday, IQVIA Holdings Inc (NYSE: IQV) reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11 . Provider of advanced analytics reported sales of $3.96 billion, al...
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
On Thursday, IQVIA Holdings Inc IQV reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11.
IQVIA beats quarterly results estimates on analytics services demand
Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.
IQVIA Holdings Inc (IQV) Q4 Earnings: EPS of $2.42 Beats Estimate, Revenue Hits $3,958 Million
IQVIA Holdings Inc (IQV) Q4 Earnings: EPS of $2.42 Beats Estimate, Revenue Hits $3,958 Million
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its catego...
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, Febru...
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a strategic ...
How Is The Market Feeling About IQVIA Hldgs?
IQVIA Hldgs's (NYSE: IQV) short percent of float has fallen 9.69% since its last report. The company recently reported that it has 2.81 million shares sold short , which is 1.77% of all regular share...
IQVIA Holdings Inc (IQV) Unveils Latest Digital Health Trends Report
IQVIA Holdings Inc (IQV) Unveils Latest Digital Health Trends Report
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite a drop in venture funding for digital health companies over the last two-and-a-half years, digital health products and solutions are expanding in...
IQVIA Holdings: Share Price Disconnected From Growth Outlook
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS ...
IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE:IQV) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations & Treasury Ari Bousbib - Chair...